Qianqian Zhou - Search Results

Year	Number of Results
2011	1
2012	2
2013	5
2014	2
2015	5
2016	8
2017	9
2018	8
2019	15
2020	11
2021	13
2022	27
2023	29
2024	11

1

Advancing targeted protein degradation for metabolic diseases therapy.

Zhou QQ, Xiao HT, Yang F, Wang YD, Li P, Zheng ZG. Zhou QQ, et al. Pharmacol Res. 2023 Feb;188:106627. doi: 10.1016/j.phrs.2022.106627. Epub 2022 Dec 21. Pharmacol Res. 2023. PMID: 36566001 Free article. Review.

2

Second generation androgen receptor antagonists and challenges in prostate cancer treatment.

Chen Y, Zhou Q, Hankey W, Fang X, Yuan F. Chen Y, et al. Among authors: zhou q. Cell Death Dis. 2022 Jul 21;13(7):632. doi: 10.1038/s41419-022-05084-1. Cell Death Dis. 2022. PMID: 35864113 Free PMC article. Review.

3

Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo.

Liu J, Zhang R, Su T, Zhou Q, Gao L, He Z, Wang X, Zhao J, Xing Y, Sun F, Cai W, Wang X, Han J, Qin R, Désaubry L, Han B, Chen W. Liu J, et al. Among authors: zhou q. J Exp Clin Cancer Res. 2023 May 20;42(1):128. doi: 10.1186/s13046-023-02695-0. J Exp Clin Cancer Res. 2023. PMID: 37210546 Free PMC article.

4

Berberine inhibits breast carcinoma proliferation and metastasis under hypoxic microenvironment involving gut microbiota and endogenous metabolites.

Sun Y, Zhou Q, Chen F, Gao X, Yang L, Jin X, Wink M, Sharopov FS, Sethi G. Sun Y, et al. Among authors: zhou q. Pharmacol Res. 2023 Jul;193:106817. doi: 10.1016/j.phrs.2023.106817. Epub 2023 Jun 12. Pharmacol Res. 2023. PMID: 37315824 Free article.

5

A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis.

Zhou Q, Zhou S, Xiong H, Yang J, Yang Z, Zhou N, Mao J, Li M. Zhou Q, et al. Clin Cosmet Investig Dermatol. 2023 Jun 12;16:1493-1497. doi: 10.2147/CCID.S412520. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37333515 Free PMC article.

6

Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment.

Zhou Q, Chen Y, Wang R, Jia F, He F, Yuan F. Zhou Q, et al. Genes Dis. 2022 Dec 27;10(6):2414-24. doi: 10.1016/j.gendis.2022.11.016. Online ahead of print. Genes Dis. 2022. PMID: 36591005 Free PMC article. Review.

7

PPFIA4 promotes castration-resistant prostate cancer by enhancing mitochondrial metabolism through MTHFD2.

Zhao R, Feng T, Gao L, Sun F, Zhou Q, Wang X, Liu J, Zhang W, Wang M, Xiong X, Jia W, Chen W, Wang L, Han B. Zhao R, et al. Among authors: zhou q. J Exp Clin Cancer Res. 2022 Apr 5;41(1):125. doi: 10.1186/s13046-022-02331-3. J Exp Clin Cancer Res. 2022. PMID: 35382861 Free PMC article.

8

Qingdai Decoction suppresses prostate cancer growth in lethal-stage prostate cancer models.

Chen Y, Zhou Q, Zhang H, Xu L, Lu L, Shu B, Zhou L, Yuan F. Chen Y, et al. Among authors: zhou q. J Ethnopharmacol. 2023 May 23;308:116333. doi: 10.1016/j.jep.2023.116333. Epub 2023 Feb 28. J Ethnopharmacol. 2023. PMID: 36863640

9

Targeting IL-6/STAT3 signaling abrogates EGFR-TKI resistance through inhibiting Beclin-1 dependent autophagy in HNSCC.

Wang Y, Zhou Q, Liu C, Zhang R, Xing B, Du J, Dong L, Zheng J, Chen Z, Sun M, Yao X, Ren Y, Zhou X. Wang Y, et al. Among authors: zhou q. Cancer Lett. 2024 Apr 1;586:216612. doi: 10.1016/j.canlet.2024.216612. Epub 2024 Jan 10. Cancer Lett. 2024. PMID: 38211653

10

[miRNA and its research advance in occupational medicine].

Hu FF, Zhou QQ, Zhu BL. Hu FF, et al. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2013 Jun;31(6):473-5. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2013. PMID: 23803553 Review. Chinese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

130 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Results by year